Skip to main content
. 2018 Feb 9;8(2):15. doi: 10.1038/s41408-018-0054-y

Fig. 1.

Fig. 1

Mortality a, major arterial and venous thrombotic complications b, myelofibrosis c, and Blast transformation d in ET, Pre-PMF, overt PMF and PV cohorts. Prevalence of previous events and cumulative incidence (CI) during follow-up calculated at 5, 10, and 15 years from diagnosis. For PMF, two different data sets were considered: n = 707 for panel a, b18 and n = 383 for panel d14 and regarding PV for all panels110